Page last updated: 2024-11-04

succinylacetone and Uveitis

succinylacetone has been researched along with Uveitis in 1 studies

succinylacetone: inhibitor of heme biosynthesis
4,6-dioxoheptanoic acid : A dioxo monocarboxylic acid that is heptanoic acid in which oxo groups replace the hydrogens at positions 4 and 6. It is an abnormal metabolite of the tyrosine metabolic pathway and a marker for type 1 tyrosinaemia.

Uveitis: Inflammation of part or all of the uvea, the middle (vascular) tunic of the eye, and commonly involving the other tunics (sclera and cornea, and the retina). (Dorland, 27th ed)

Research Excerpts

ExcerptRelevanceReference
"The effects of succinylacetone (SA) on the development of S-antigen-induced experimental autoimmune uveitis (EAU) in the rat were studied."7.67Treatment of experimental autoimmune uveitis in the rat with systemic succinylacetone. ( Blaese, RM; Hess, RA; Nussenblatt, RB; Palestine, AG; Skolik, SA, 1988)
"The effects of succinylacetone (SA) on the development of S-antigen-induced experimental autoimmune uveitis (EAU) in the rat were studied."3.67Treatment of experimental autoimmune uveitis in the rat with systemic succinylacetone. ( Blaese, RM; Hess, RA; Nussenblatt, RB; Palestine, AG; Skolik, SA, 1988)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Skolik, SA1
Palestine, AG1
Blaese, RM1
Nussenblatt, RB1
Hess, RA1

Other Studies

1 other study available for succinylacetone and Uveitis

ArticleYear
Treatment of experimental autoimmune uveitis in the rat with systemic succinylacetone.
    Clinical immunology and immunopathology, 1988, Volume: 49, Issue:1

    Topics: Animals; Autoimmune Diseases; Dose-Response Relationship, Drug; Female; Heptanoates; Heptanoic Acids

1988